BEGIN:VCALENDAR VERSION:2.0 PRODID:-//BioCT - ECPv6.3.3.1//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:BioCT X-ORIGINAL-URL:https://bioct.org X-WR-CALDESC:Events for BioCT REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20210314T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20211107T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20210624T163000 DTEND;TZID=America/New_York:20210624T180000 DTSTAMP:20240329T030640 CREATED:20210607T170352Z LAST-MODIFIED:20210607T170436Z UID:4784-1624552200-1624557600@bioct.org SUMMARY:YSIF Advanced Therapies - RNA Therapeutics: RIGImmune DESCRIPTION:Yale Startups in Formation (YSIF) is a program for entrepreneurial faculty founded and directed by the Office of Cooperative Research. Each YSIF meeting is designed to be partly educational and partly new venture seminar\, aiming to serve Yale innovators and their co-founders as these teams launch their businesses. \nHost: \nJames G. Boyle\, PhD\, Executive Director\, Faculty Entrepreneurship & Venture Development Yale Office of Cooperative Research \nModerator: \nRoy Herbst\, MD\, PhD: Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Chief of Medical Oncology\, Yale Cancer Center and Smilow Cancer Hospital; Associate Cancer Center Director\, Translational Science \nExpert Panelists: \n• Anna Marie Pyle\, PhD\, Co-Founder\, RIGImmune\, Inc.. Sterling Professor of Molecular\, Cellular & Developmental Biology; Investigator Howard Hughes Med Inst; Prof Chemistry \n• Akiko Iwasaki\, PhD\, Co-Founder\, RIGImmune\, Inc.. Waldemar Von Zedtwitz Professor of Immunobiology and Molecular\, Cellular and Developmental Biology and Professor of Epidemiology (Microbial Diseases); Professor of Molecular Cellular and Developmental Biology; Investigator\, Howard Hughes Medical Institute \n• Marty Driscoll\, Executive Chair RIGImmune\, Inc. \n• Donald Corcoran\, Advisor: Business Development\, RIGImmune\, Inc. URL:https://bioct.org/event/ysif-advanced-therapies-rna-therapeutics-rigimmune/ END:VEVENT END:VCALENDAR